vildagliptin 100 mg Sustained Release Tab Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
vildagliptin 100 mg Sustained Release Tab Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: DPP-4 inhibitor
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our vildagliptin 100 mg Sustained Release Tab Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following vildagliptin 100 mg Sustained Release Tab Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
vildagliptin 100 mg Sustained Release Tab Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our vildagliptin 100 mg Sustained Release Tab formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Type-2 diabetes mellitus
- Add-on to metformin or pioglitazone
- Glycaemic intensification
Mechanism of Action
Vildagliptin inhibits DPP-4, prolonging incretin (GLP-1, GIP) action. Increased glucose-dependent insulin secretion and decreased glucagon release improve glycaemic control without producing hypoglycaemia in non-eugenic states.
Dosage & Administration
- Adults: take with or without food
- Adjust dose in renal impairment
- Monitor liver enzymes periodically
- Use under physician supervision
Side Effects
- Nasopharyngitis
- Headache
- Hypoglycaemia (with SU/insulin)
- Hepatic enzyme elevation (rare)
- GI upset (with metformin component)
Contraindications
- Type-1 diabetes
- Diabetic ketoacidosis
- Significant hepatic impairment
- Pregnancy and breastfeeding
Storage
Store below 25°C.
PCD Pharma Franchise for vildagliptin 100 mg Sustained Release Tab Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu-Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for vildagliptin 100 mg Sustained Release Tab Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of vildagliptin 100 mg Sustained Release Tab Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of vildagliptin 100 mg Sustained Release Tab Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of vildagliptin 100 mg Sustained Release Tab Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is vildagliptin 100 mg Sustained Release Tab Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer vildagliptin 100 mg Sustained Release Tab Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for vildagliptin 100 mg Sustained Release Tab Tablet?
Available pack sizes include: 10 x 10 (Alu-Alu).
What is the MRP / trade price for vildagliptin 100 mg Sustained Release Tab Tablet?
MRPs range from ₹1650 to ₹1650 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for vildagliptin 100 mg Sustained Release Tab Tablet?